Rafael Tordjman is Director & 10% at Flexion Therapeutics Inc (FLXN). They have made 1 open-market trade across 1 company since 2014, most recently 2014-02-18.
CIK 0001597789
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $3.0M since 2014, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FLXN | 2,105,491 | $50.6M |
Shares reported on the most recent Form 4, priced at the 2014-02-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FLXN | BUY | 2014-02-18 | 2014-02-20 | $13.00 | $3.0M | -19.2% | -4.0% | -4.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.